Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
688505
Company Profile
Business description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.
Contact
308 Cailun Road
Zhangjiang Hi-Tech Park
Pudong
Shanghai201210
CHNT: +86 2158953355
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
925
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,853.70 | 60.20 | -0.76% |
| CAC 40 | 7,120.79 | 5.23 | -0.07% |
| DAX 40 | 20,466.79 | 95.94 | -0.47% |
| Dow JONES (US) | 39,577.49 | 1,030.96 | -2.54% |
| FTSE 100 | 7,910.88 | 2.37 | -0.03% |
| HKSE | 20,945.67 | 263.89 | 1.28% |
| NASDAQ | 16,387.31 | 737.66 | -4.31% |
| Nikkei 225 | 33,585.58 | 1,023.42 | -2.96% |
| NZX 50 Index | 12,019.13 | 182.30 | -1.49% |
| S&P 500 | 5,276.03 | 180.87 | -3.31% |
| S&P/ASX 200 | 7,646.50 | 63.10 | -0.82% |
| SSE Composite Index | 3,238.23 | 14.59 | 0.45% |